NHS cancer patients denied life-saving drugs due to Brexit costs, report finds

Exclusive: Britons found to have lost out' while rest of Europe benefits from golden age of research and treatments

• Children with cancer cannot wait': the human cost of clinical trial delays after Brexit

British cancer patients are being denied life-saving drugs and trials of revolutionary treatments are being derailed by the red tape and extra costs brought on by Brexit, a leaked report warns.

Soaring numbers are being diagnosed with the disease amid a growing and ageing population, improved diagnosis initiatives and wider public awareness - making global collaborations to find new medicines essential.